Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery
NCT ID: NCT04951752
Last Updated: 2021-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
307 participants
OBSERVATIONAL
2021-04-14
2021-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continuous TQL Block for Elective Cesarean Section
NCT03663478
Effect of Volume of Local Anesthetic for Adductor Canal Block on Quadriceps Muscle Function: A Dose Finding Study
NCT02541552
Comparison of Two Analgesic Strategies After Scheduled Caesarean
NCT04755712
A Study Investigating Properties of the Transversus Abdominis Plane Block
NCT01679392
Effects of Local Anaesthetic Infusion Rates on Nerve Block Duration
NCT02801799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hemicolectomy, Active treatment
2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block
Ropivacaine injection
Transmuscular quadratus lumborum block - active
Hemicolectomy, Placebo treatment
2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block
No interventions assigned to this group
Nephrectomy, Active treatment
2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block
Ropivacaine injection
Transmuscular quadratus lumborum block - active
Nephrectomy, Placebo treatment
2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block
No interventions assigned to this group
Percutaneous nephrolithotomy, Active treatment
1x30mL 0.75% Ropivacaine administered by way of transmuscular quadratus lumborum block
Ropivacaine injection
Transmuscular quadratus lumborum block - active
Percutaneous nephrolithotomy, Placebo treatment
1x30mL isotonic saline administered by way of transmuscular quadratus lumborum block
No interventions assigned to this group
Hysterectomy, Active treatment
2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block
Ropivacaine injection
Transmuscular quadratus lumborum block - active
Hysterectomy, Placebo treatment
2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block
No interventions assigned to this group
Elective Caesarean section, Active treatment
2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block
Ropivacaine injection
Transmuscular quadratus lumborum block - active
Elective Caesarean section, Placebo treatment
2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine injection
Transmuscular quadratus lumborum block - active
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Allergy to local anaesthetics or opioids
* Inability to understand Danish
* Regular intake of opioids
* Local infection at site of injection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zealand University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jens Børglum Neimann, MD, PhD
Role: STUDY_DIRECTOR
Associate Professor, Zealand University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zealand University Hospital
Roskilde, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dam M, Hansen C, Poulsen TD, Azawi NH, Laier GH, Wolmarans M, Chan V, Bendtsen TF, Borglum J. Transmuscular quadratus lumborum block reduces opioid consumption and prolongs time to first opioid demand after laparoscopic nephrectomy. Reg Anesth Pain Med. 2021 Jan;46(1):18-24. doi: 10.1136/rapm-2020-101745. Epub 2020 Oct 26.
Hansen CK, Dam M, Steingrimsdottir GE, Laier GH, Lebech M, Poulsen TD, Chan VWS, Wolmarans M, Bendtsen TF, Borglum J. Ultrasound-guided transmuscular quadratus lumborum block for elective cesarean section significantly reduces postoperative opioid consumption and prolongs time to first opioid request: a double-blind randomized trial. Reg Anesth Pain Med. 2019 Jul 14:rapm-2019-100540. doi: 10.1136/rapm-2019-100540. Online ahead of print.
Dam M, Hansen CK, Poulsen TD, Azawi NH, Wolmarans M, Chan V, Laier GH, Bendtsen TF, Borglum J. Transmuscular quadratus lumborum block for percutaneous nephrolithotomy reduces opioid consumption and speeds ambulation and discharge from hospital: a single centre randomised controlled trial. Br J Anaesth. 2019 Aug;123(2):e350-e358. doi: 10.1016/j.bja.2019.04.054. Epub 2019 May 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SOPRE-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.